Eyegene Stock Total Asset
| 185490 Stock | KRW 2,830 15.00 0.53% |
EyeGene fundamentals help investors to digest information that contributes to EyeGene's financial success or failures. It also enables traders to predict the movement of EyeGene Stock. The fundamental analysis module provides a way to measure EyeGene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to EyeGene stock.
EyeGene |
EyeGene Company Total Asset Analysis
EyeGene's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current EyeGene Total Asset | 104.99 B |
Most of EyeGene's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, EyeGene is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
Based on the latest financial disclosure, EyeGene has a Total Asset of 104.99 B. This is much higher than that of the sector and significantly higher than that of the Biotechnology industry. The total asset for all Republic of Korea stocks is notably lower than that of the firm.
EyeGene Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EyeGene's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of EyeGene could also be used in its relative valuation, which is a method of valuing EyeGene by comparing valuation metrics of similar companies.EyeGene is currently under evaluation in total asset category among its peers.
EyeGene Fundamentals
| Return On Equity | -51.2 | |||
| Return On Asset | -0.19 | |||
| Operating Margin | (3.95) % | |||
| Current Valuation | 576.45 B | |||
| Shares Outstanding | 10.99 M | |||
| Shares Owned By Insiders | 9.70 % | |||
| Shares Owned By Institutions | 0.30 % | |||
| Price To Sales | 66.02 X | |||
| Revenue | 3.24 B | |||
| Gross Profit | 1.54 B | |||
| EBITDA | (12.07 B) | |||
| Net Income | (34.57 B) | |||
| Cash And Equivalents | 1.04 B | |||
| Total Debt | 676.06 M | |||
| Debt To Equity | 1.60 % | |||
| Current Ratio | 4.91 X | |||
| Cash Flow From Operations | (30 B) | |||
| Number Of Employees | 63 | |||
| Beta | 0.56 | |||
| Market Capitalization | 69.04 B | |||
| Total Asset | 104.99 B | |||
| Z Score | 61.2 | |||
| Net Asset | 104.99 B |
About EyeGene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze EyeGene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EyeGene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EyeGene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with EyeGene
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EyeGene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EyeGene will appreciate offsetting losses from the drop in the long position's value.Moving against EyeGene Stock
| 0.7 | 226950 | OliX PharmaceuticalsInc | PairCorr |
| 0.58 | 105560 | KB Financial Group | PairCorr |
| 0.42 | 047810 | Korea Aerospace Indu | PairCorr |
| 0.31 | 298380 | ABL Bio | PairCorr |
The ability to find closely correlated positions to EyeGene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EyeGene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EyeGene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling EyeGene to buy it.
The correlation of EyeGene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EyeGene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if EyeGene moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EyeGene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in EyeGene Stock
EyeGene financial ratios help investors to determine whether EyeGene Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EyeGene with respect to the benefits of owning EyeGene security.